Innate Pharma IPHA
NASDAQ IPHA
$2.27 +0.18 (+8.37%)
As of: Aug 21, 2026 · 11:22 AM EDT

Innate Pharma (IPHA) FCF Margin Growth (3y) (2022 - 2025)

Innate Pharma (IPHA) FCF Margin Growth (3y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.97 Bn 132.12 Bn 2.84 Bn -1,272.00
2 Regeneron Pharmaceuticals 86.64 Bn 78.64 Bn 3.93 Bn -2,228.00
3 Argenx Se 65.55 Bn 60.37 Bn 1.37 Bn -
4 Moderna 61.26 Bn 56.12 Bn 52.00 Mn -5,426.00
5 BeOne Medicines 42.30 Bn 37.20 Bn 1.53 Bn 9,545.00
6 Alnylam Pharmaceuticals 31.66 Bn 28.35 Bn 992.69 Mn 4,612.00
7 BioNTech SE 28.68 Bn 10.29 Bn 668.28 Mn 1,850.00
8 Insmed 27.54 Bn 26.38 Bn 358.27 Mn 14,060.00
9 Royalty Pharma 27.26 Bn 26.42 Bn - -3,088.00
10 Innate Pharma 204.27 Mn 204.27 Mn - -188,783.00

Historic Data

Download Data
DateValue
Dec 31, 2025 502.00
Dec 31, 2024 -457.00
Dec 31, 2023 -94.00
Dec 31, 2022 -184.00